Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
156,417,705
-
Share change
-
+4,174,538
-
Total reported value
-
$1,726,071,008
-
Put/Call ratio
-
53%
-
Price per share
-
$11.04
-
Number of holders
-
227
-
Value change
-
+$13,073,879
-
Number of buys
-
137
-
Number of sells
-
108
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2022
As of 30 Jun 2022,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
227 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
156,417,705 shares.
The largest 10 holders included
VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, STATE STREET CORP, BlackRock Inc., Avoro Capital Advisors LLC, FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, PICTET ASSET MANAGEMENT SA, FARALLON CAPITAL MANAGEMENT LLC, and AMERIPRISE FINANCIAL INC.
This page lists
227
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.